Literature DB >> 21412659

A Brazilian family with hereditary inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia.

R D Fanganiello1, V E Kimonis, C C Côrte, R Nitrini, M R Passos-Bueno.   

Abstract

Inclusion body myopathy associated with Paget disease and frontotemporal dementia (IBMPFD) is a progressive and usually misdiagnosed autosomal dominant disorder. It is clinically characterized by a triad of features: proximal and distal myopathy, early onset Paget disease of bone (PDB), and frontotemporal dementia (FTD). It is caused by missense mutations in the valosin-containing protein (VCP) gene. We describe here the clinical and molecular findings of the first Brazilian family identified with IBMPFD. Progressive myopathy affecting the limb girdles was detected by clinical examination followed by muscle biopsy and creatine kinase measurement. PDB was suggested after anatomopathological bone examination and FTD was diagnosed by clinical, neuropsychological and language evaluations. Brain magnetic resonance revealed severe atrophy of the anterior temporal lobes, including the hippocampi. A R93C mutation in VCP was detected by direct sequencing screening in subject W (age 62) and in his mother. Four more individuals diagnosed with "dementia" were reported in this family. We also present a comprehensive genotype-phenotype correlation analysis of mutations in VCP in 182 patients from 29 families described in the literature and show that while IBM is a conspicuously penetrant symptom, PDB has a lower penetrance when associated with mutations in the AAAD1 domain and FTD has a lower penetrance when associated with mutations in the Junction (L1-D1) domain. Furthermore, the R93C mutation is likely to be associated with the penetrance of all the clinical symptoms of the triad.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21412659     DOI: 10.1590/s0100-879x2011007500028

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  13 in total

Review 1.  Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Suvi Häkkinen; Stephanie A Chu; Suzee E Lee
Journal:  Neurobiol Dis       Date:  2020-09-02       Impact factor: 5.996

Review 2.  A Brazilian family with inclusion body myopathy associated with Paget's disease of bone and frontotemporal dementia linked to the VCP pGly97Glu mutation.

Authors:  Samuel Katsuyuki Shinjo; Sueli Mieko Oba-Shinjo; Antonio Marcondes Lerario; Suely Kazue Nagahashi Marie
Journal:  Clin Rheumatol       Date:  2017-11-10       Impact factor: 2.980

3.  Genotype-phenotype study in patients with valosin-containing protein mutations associated with multisystem proteinopathy.

Authors:  E Al-Obeidi; S Al-Tahan; A Surampalli; N Goyal; A K Wang; A Hermann; M Omizo; C Smith; T Mozaffar; V Kimonis
Journal:  Clin Genet       Date:  2018-01       Impact factor: 4.438

Review 4.  The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis.

Authors:  Angèle Nalbandian; Sandra Donkervoort; Eric Dec; Mallikarjun Badadani; Veeral Katheria; Prachi Rana; Christopher Nguyen; Jogeshwar Mukherjee; Vincent Caiozzo; Barbara Martin; Giles D Watts; Jouni Vesa; Charles Smith; Virginia E Kimonis
Journal:  J Mol Neurosci       Date:  2011-09-03       Impact factor: 3.444

5.  Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia.

Authors:  S G Mehta; M Khare; R Ramani; G D J Watts; M Simon; K E Osann; S Donkervoort; E Dec; A Nalbandian; J Platt; M Pasquali; A Wang; T Mozaffar; C D Smith; V E Kimonis
Journal:  Clin Genet       Date:  2012-10-04       Impact factor: 4.438

6.  Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis.

Authors:  Paloma González-Pérez; Elizabeth T Cirulli; Vivian E Drory; Ron Dabby; Puiu Nisipeanu; Ralph L Carasso; Menachem Sadeh; Andrew Fox; Barry W Festoff; Peter C Sapp; Diane McKenna-Yasek; David B Goldstein; Robert H Brown; Sergiu C Blumen
Journal:  Neurology       Date:  2012-11-14       Impact factor: 9.910

7.  The homozygote VCP(R¹⁵⁵H/R¹⁵⁵H) mouse model exhibits accelerated human VCP-associated disease pathology.

Authors:  Angèle Nalbandian; Katrina J Llewellyn; Masashi Kitazawa; Hong Z Yin; Mallikarjun Badadani; Negar Khanlou; Robert Edwards; Christopher Nguyen; Jogeshwar Mukherjee; Tahseen Mozaffar; Giles Watts; John Weiss; Virginia E Kimonis
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

8.  IBMPFD Disease-Causing Mutant VCP/p97 Proteins Are Targets of Autophagic-Lysosomal Degradation.

Authors:  Oznur Bayraktar; Ozlem Oral; Nur Mehpare Kocaturk; Yunus Akkoc; Karin Eberhart; Ali Kosar; Devrim Gozuacik
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

Review 9.  Inclusion body myositis - pathomechanism and lessons from genetics.

Authors:  Balázs Murnyák; Levente Bodoki; Melinda Vincze; Zoltán Griger; Tamás Csonka; Rita Szepesi; Andrea Kurucz; Katalin Dankó; Tibor Hortobágyi
Journal:  Open Med (Wars)       Date:  2015-02-26

10.  Exercise training reverses skeletal muscle atrophy in an experimental model of VCP disease.

Authors:  Angèle Nalbandian; Christopher Nguyen; Veeral Katheria; Katrina J Llewellyn; Mallikarjun Badadani; Vincent Caiozzo; Virginia E Kimonis
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.